- Home
- PRCH vs DYN Comparison
PRCH vs DYN Comparison
Compare PRCH & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRCH
- DYN
- Stock Information
- Founded
- PRCH 2012
- DYN 1984
- Country
- PRCH United States
- DYN United States
- Employees
- PRCH N/A
- DYN N/A
- Industry
- PRCH Computer Software: Prepackaged Software
- DYN Medicinal Chemicals and Botanical Products
- Sector
- PRCH Technology
- DYN Health Care
- Exchange
- PRCH Nasdaq
- DYN Nasdaq
- Market Cap
- PRCH 1.6B
- DYN 1.4B
- IPO Year
- PRCH N/A
- DYN 2020
- Fundamental
- Price
- PRCH $16.63
- DYN $12.58
- Analyst Decision
- PRCH Strong Buy
- DYN Strong Buy
- Analyst Count
- PRCH 7
- DYN 15
- Target Price
- PRCH $13.71
- DYN $36.00
- AVG Volume (30 Days)
- PRCH 2.0M
- DYN 2.9M
- Earning Date
- PRCH 08-05-2025
- DYN 07-28-2025
- Dividend Yield
- PRCH N/A
- DYN N/A
- EPS Growth
- PRCH N/A
- DYN N/A
- EPS
- PRCH 0.52
- DYN N/A
- Revenue
- PRCH $435,601,000.00
- DYN N/A
- Revenue This Year
- PRCH N/A
- DYN N/A
- Revenue Next Year
- PRCH $14.98
- DYN N/A
- P/E Ratio
- PRCH $31.60
- DYN N/A
- Revenue Growth
- PRCH N/A
- DYN N/A
- 52 Week Low
- PRCH $1.16
- DYN $6.36
- 52 Week High
- PRCH $17.38
- DYN $47.06
- Technical
- Relative Strength Index (RSI)
- PRCH 64.70
- DYN 67.54
- Support Level
- PRCH $14.32
- DYN $11.65
- Resistance Level
- PRCH $16.24
- DYN $12.68
- Average True Range (ATR)
- PRCH 1.12
- DYN 0.78
- MACD
- PRCH 0.06
- DYN 0.11
- Stochastic Oscillator
- PRCH 83.55
- DYN 74.52
About PRCH Porch Group Inc.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.